Form S-3ASR Avalo Therapeutics Inc For: 5 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avalo Therapeutics Inc (AVTX)
Track the Avalo Therapeutics share price today and view real-time AVTX share price data, including charts, technicals, and key financials. View the AVTX premarket stock price ahead of the market session or assess the after hours quote. Explore AVTX stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Avalo Therapeutics Stock Price Today?
The Avalo Therapeutics stock price today is 6.890.
What Is the Stock Symbol for Avalo Therapeutics?
The stock symbol for Avalo Therapeutics is ""AVTX.""
What Stock Exchange Does Avalo Therapeutics Trade On?
Avalo Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Avalo Therapeutics a Good Stock to Buy?
Determining whether Avalo Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVTX quote. (ISIN: US05338F3064)
What Is the Avalo Therapeutics Stock Price Today?
The Avalo Therapeutics stock price today is 6.890.
What Is the Stock Symbol for Avalo Therapeutics?
The stock symbol for Avalo Therapeutics is ""AVTX.""
What Stock Exchange Does Avalo Therapeutics Trade On?
Avalo Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Avalo Therapeutics a Good Stock to Buy?
Determining whether Avalo Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVTX quote. (ISIN: US05338F3064)
6.890
-0.180(-2.55%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.670
6.900
52 wk Range
6.530
24.270
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.6706.900
52 wk Range
6.53024.270
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AVTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
36.600
Upside
+431.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 424B5 Avalo Therapeutics Inc For: 5 November- Investing.com
- Form S-3ASR Avalo Therapeutics Inc For: 5 November
- Investing.com
- Form 424B5 Avalo Therapeutics Inc For: 5 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
12 Buy
2 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 36.600
(+431.20% Upside)
Earnings
Latest Release
05/11/2026
EPS / Forecast
-0.34 / -0.59
Revenue / Forecast
-- / --
Compare AVTX to Peers and Sector
Metrics to compare | AVTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.8x | −1.8x | −0.2x | |
PEG Ratio | −0.08 | −0.06 | 0.00 | |
Price/Book | 0.8x | 2.5x | 2.6x | |
Price / LTM Sales | 6,426.5x | 50.4x | 2.8x | |
Upside (Analyst Target) | - | 145.5% | 62.7% | |
Fair Value Upside | Unlock | 17.4% | 8.0% | Unlock |
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Avalo Therapeutics (AVTX) Stock Price Today?
The Avalo Therapeutics stock price today is 6.890 USD.
What Stock Exchange Does Avalo Therapeutics Trade On?
Avalo Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Avalo Therapeutics?
The stock symbol for Avalo Therapeutics is "AVTX."
What Is the Avalo Therapeutics Market Cap?
As of today, Avalo Therapeutics market cap is 367.100M USD.
What Is Avalo Therapeutics's Earnings Per Share (TTM)?
The Avalo Therapeutics EPS (TTM) is -4.18.
From a Technical Analysis Perspective, Is AVTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Avalo Therapeutics Stock Split?
Avalo Therapeutics has split 2 times.
How Many Employees Does Avalo Therapeutics Have?
Avalo Therapeutics has 33 employees.
What is the current trading status of Avalo Therapeutics (AVTX)?
As of 05/11/2026, Avalo Therapeutics (AVTX) is trading at a price of 6.890 USD, with a previous close of 7.070 USD. The stock has fluctuated within a day range of 6.670 USD to 6.900 USD, while its 52-week range spans from 6.530 USD to 24.270 USD.
What Is Avalo Therapeutics (AVTX) Price Target According to Analysts?
The average 12-month price target for Avalo Therapeutics is 36.600 USD, with a high estimate of 60 USD and a low estimate of 10 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +431.20% Upside potential.
What Is the AVTX Premarket Price?
AVTX's last pre-market stock price is 6.700 USD. The pre-market share volume is 6,620.000, and the stock has decreased by -0.370, or -5.230%.
What Is the AVTX After Hours Price?
AVTX's last after hours stock price is 7.050 USD, the stock has decreased by -0.020, or -0.280%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.